XML 31 R6.htm IDEA: XBRL DOCUMENT v3.2.0.727
Statements of Cash Flows - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2015
Jun. 30, 2014
CASH FLOWS USED IN OPERATING ACTIVITIES:    
Net loss $ (40,022) $ (27,097)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 78 33
Amortization of premium (accretion of discount) on marketable securities, net 682  
Stock-based compensation expense 5,850 1,815
Research and development expense settled in stock   2,717
Change in fair value of other current assets, warrant liability and other liability   505
Non-cash interest 156 127
Loss on retirement of note payable   57
Changes in operating assets and liabilities:    
Prepaid expenses and other current assets (1,006) (1,420)
Other long-term assets (30) (150)
Accounts payable 999 888
Accrued expenses and other current liabilities (5,906) 3,254
Net cash used in operating activities (39,199) (19,271)
CASH FLOWS USED IN INVESTING ACTIVITIES:    
Purchases of property and equipment (186) (29)
Purchases of marketable securities (179,338) (30,649)
Sales and maturities of marketable securities 75,802  
Net cash provided by (used in) investing activities (103,722) (30,678)
CASH FLOWS PROVIDED BY FINANCING ACTIVITIES:    
Proceeds from note payable, net   20,568
Payments on note payable   (13,156)
Proceeds from the issuance of common stock, net 158,414 51,332
Deferred financing costs   (95)
Proceeds from the issuance of preferred stock, net   27,368
Proceeds from exercise of stock options 359  
Net cash provided by financing activities 158,773 86,017
NET INCREASE IN CASH AND CASH EQUIVALENTS 15,852 36,068
CASH AND CASH EQUIVALENTS AT BEGINNING OF YEAR 28,518 12,303
CASH AND CASH EQUIVALENTS AT END OF YEAR 44,370 48,371
SUPPLEMENTAL DISCLOSURES:    
Cash paid for interest $ 1,253 555
NON-CASH FINANCING ACTIVITIES:    
Accretion of dividends on preferred stock   9,000
Fair value of series A-6 convertible preferred stock issued as settlement of liability   10,109
Fair value of warrants issued   1,511
Initial public offering costs included in accrued expenses and other current liabilities   1,182
Reclassification of preferred stock to common stock   $ 298,063